Featured Articles
-
Borrowed Brilliance: Is Pharma Becoming Overly Reliant On Acquisitions?
4/15/2025
Denise Bronner, Ph.D., makes the case for and against acquisitions for rejuvenating Big Pharma pipelines. She explains why outsourcing innovation can be as risky, and costly, as internal discovery.
-
Securing Capital At The Right Moment: How Much Should Startups Ask For?
4/11/2025
When funding is tight, life sciences startups must be even more strategic with requested amounts, timing, and funding sources, explains Michael Brooder.
-
How HHS Budget Cuts And Vaccine Hesitancy Threaten Clinical Trial Operations — And What Leaders Can Do
4/10/2025
Prof. Stacey B. Lee, Ph.D., examines how the recent Department of Health and Human Services (HHS) staffing cuts and vaccine hesitancy combine to make clinical research much more challenging.
-
Understanding Re-Narcotization Is Key To Battling Opioids Like Fentanyl
4/9/2025
Current short-acting opioid rescue agents were not designed to counteract oral fentanyl overdoses, and the mismatch can be dangerous, explains Elysium Therapeutics' Tom Jenkins, Ph.D.
-
Amgen's Ian Thompson On Leadership And A Global Mindset
4/8/2025
Ian Thompson, SVP and general manager of U.S. business operations at Amgen, shares his leadership philosophy, what he's learned from working in global markets, and key pipeline highlights.
-
How AI Redefines The Functional Service Provider Opportunity In Medical Affairs
4/7/2025
Medical affairs can no longer afford to operate within legacy structures. Enter AI-enabled functional service provider (FSP) models that offer operational relief.
-
Biopharma Should Focus On Product Iteration Over Product Launches
4/4/2025
Building iteration into the product commercialization process can help life sciences companies avoid many of the missteps that slow down adoption and stall growth, explains Jessica Meng.
-
Breaking Barriers: From Gendered Perceptions To Inclusive Leadership
4/2/2025
Leadership in pharma means questioning assumptions, amplifying diverse voices, and creating environments where authenticity and empathy are recognized as strengths, explains Laryssa Wozniak.
-
Risk Management Planning: Be Prepared When Disaster Strikes
4/1/2025
Few life sciences companies are ready for a disaster, particularly a cyber one. Key factors include an integrated approach to cyber preparedness and risk planning, a dedicated team, and more.
-
Companies To Watch: Imunon
3/31/2025
Imunon aims to shake up the standard of care in the frontline treatment of advanced ovarian cancer.